EQL Pharma Q2 Operating Profit Surges to SEK 22.4M from SEK 3.6M

EQL Pharma's Q2 operating profit jumped to 22.4 million kronor from 3.6 million a year earlier, a six-fold increase. The sharp improvement signals strong operational leverage or one-off gains, but the driver is unspecified. This is a notable earnings beat for a small-cap pharma, likely to attract investor attention.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works